QUOTE AND NEWS
Market Intelligence Center  Jul 24  Comment 
Jazz Pharmaceuticals Inc. (JAZZ) presents a trading opportunity that offers a 5.19% return in just 58 days. A covered call on Jazz Pharmaceuticals at the $145.00 level expiring on Sep. '14 offers an assigned return rate of 5.19% or 32.64%...
StreetInsider.com  Jul 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+%28JAZZ%29+Concert+%28CNCE%29+Initiate+First+Phase+1+Clinical+Trial+of+JZP-386/9676319.html for the full story.
StreetInsider.com  Jul 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+Pharmaceuticals+%28JAZZ%29+To+Acquire+Rights+To+Defibrotide+for+%2475M/9631892.html for the full story.
Market Intelligence Center  Jul 1  Comment 
Jazz Pharmaceuticals Inc. (JAZZ) presents a trading opportunity that offers a 7.16% return in just 81 days. A covered call on Jazz Pharmaceuticals at the $145.00 level expiring on Sep. '14 offers an assigned return rate of 7.16% or 32.27%...
Market Intelligence Center  Jun 19  Comment 
Jazz Pharmaceuticals Inc. (JAZZ) presents a trading opportunity that offers a 7.89% return in just 93 days. A covered call on Jazz Pharmaceuticals at the $150.00 level expiring on Sep. '14 offers an assigned return rate of 7.89% or 30.97%...
StreetInsider.com  Jun 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+%28JAZZ%29+Presents+JZP-110+Phase+2b+Data+For+The+Treatment+Of+EDS+/9544404.html for the full story.
Market Intelligence Center  May 27  Comment 
Jazz Pharmaceuticals Inc. (JAZZ) traded between $131.36 and $135.68 before closing at $135.37 Friday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s algorithms have picked a Jul. '14 $135.00 covered call...
Market Intelligence Center  May 20  Comment 
MarketIntelligenceCenter.com’s patented algorithms have chosen the Sep. '14 $130.00 call for a couple of hedged-trading ideas on Jazz Pharmaceuticals Inc. (JAZZ). A traditional covered call on Jazz Pharmaceuticals yields 9.49% (28.17%...
StreetInsider.com  May 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Jazz+Pharmaceuticals+%28JAZZ%29+Appoints+Russ+Cox+as+COO/9502131.html for the full story.
SeekingAlpha  May 9  Comment 
Jazz Pharmaceuticals Public Limited (JAZZ) Q1 2014 Earnings Call May 08, 2014 4:30 pm ET Executives Katherine A. Littrell - Vice President of Investor Relations Bruce C. Cozadd - Co-Founder, Executive Chairman and Chief Executive...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki